Back to search

Article

B cells engineered to express pathogen-specific antibodies using CRISPR/Cas9 protect against infection

2019-02-06

Abstract excerpt

Effective vaccines inducing lifelong protection against many important infections such as respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), influenza and Epstein-Barr virus (EBV) are not yet available despite decades of research. As an alternative to a protective vaccine we developed a genetic engineering strategy in which CRISPR/Cas9 was utilized to replace endogenously-encoded antibodies wit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
91db7e68-0557-5985-bfd9-31a3f2bfc438
DOI
10.1101/541979
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
B cells engineered to express pathogen-specific antibodies using CRISPR/Cas9 protect against infectionDOI 10.1101/541979
Select a neighboring publication to make it the new centre.